It is important for primary care providers to understand new federal regulations surrounding wearables, wellness and clinical ...
Alongside the approval of Ponlimsi, the FDA is reviewing a BLA for TEV-45779, a biosimilar candidate for Xolair, covering all currently approved indications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results